Advanced search
Publication Cover
Bioengineered Volume 11, 2020 - Issue 1
Submit an article Journal homepage
12,806
Views
141
CrossRef citations to date
0
Altmetric
Review

Advanced in developmental organic and inorganic nanomaterial: a review

Khalisanni Khalida Malaysian Agricultural Research and Development Institute (MARDI), Serdang, Malaysia;b Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, MalaysiaCorrespondence[email protected] [email protected]
,
Xuefei Tanc College of Materials and Chemical Engineering, Heilongjiang Institute of Technology, Harbin, PR China;d State Key Laboratory of Urban Water Resource and Environment, School of Environment, Harbin Institute of Technology, Harbin, PR China;e Dalian SEM Bio-Engineering Technology Co., Ltd, Dalian, PR China
,
Hayyiratul Fatimah Mohd Zaidf Fundamental and Applied Sciences Department, Centre of Innovative Nanostructures & Nanodevices (COINN), Institute of Autonomous System, Universiti Teknologi PETRONAS, Bandar Seri Iskandar, Malaysia
,
Yang Taog College of Food Science and Technology, Nanjing Agricultural University, Nanjing, China
,
Chien Lye Chewh Sime Darby Plantation Research (Formerly Known as Sime Darby Research), R&D Centre – Carey Island, Pulau Carey, Malaysia
,
Dinh-Toi Chui Faculty of Biology, Hanoi National University of Education, Hanoi, Vietnam;j Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Norway
,
Man Kee Lamk Department of Chemical Engineering, Universiti Teknologi PETRONAS, Seri Iskandar, Malaysia
,
Yeek-Chia Hol Civil and Environmental Engineering Department, Univesiti Teknologi PETRONAS, Seri Iskandar, Malaysia;m Center for Urban Resource Sustainably, Institute of Self-Sustainable Building, Universiti Teknologi PETRONAS, Seri Iskandar, MalaysiaORCID Iconhttps://orcid.org/0000-0002-2820-9696
ORCID Icon,
Jun Wei Limn Department of Fundamental and Applied Sciences, Universiti Teknologi PETRONAS, Seri Iskandar, Malaysia;o Centre for Biofuel and Biochemical Research, Institute of Self-Sustainable Building, Universiti Teknologi PETRONAS, Seri Iskandar, Malaysia LimORCID Iconhttps://orcid.org/0000-0003-0158-8822
ORCID Icon &
Lai Chin Weip Nanotechnology & Catalysis Research Centre (NANOCAT), University of Malaya (UM), Kuala Lumpur, MalaysiaORCID Iconhttps://orcid.org/0000-0002-7549-5015
ORCID Icon show all
Pages 328-355 | Received 12 Jan 2020, Accepted 17 Feb 2020, Published online: 06 Mar 2020

References

  • Bianco A, Cheng HM, Enoki T, et al. (2013). All in the graphene family–a recommended nomenclature for two-dimensional carbon materials.Carbon. 2013; 65: 1-6
  • Eustis S, El-Sayed MA. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev. 2006;35(3):209–217.
  • Bogani L, Wernsdorfer W. Molecular spintronics using single-molecule magnets. Nanosci Technol. 2010;7(3):194–201.
  • Awade MKL. Emerging trends of nanotechnology in biomedical engineering. Int J Electron Comm Eng Technol. 2010;1(1):25–32.
  • Tiwari JN, Tiwari RN, Kim KS. Zero-dimensional, one-dimensional, two-dimensional and three-dimensional nanostructured materials for advanced electrochemical energy devices. Pro Mater Sci. 2012;57(4):724–803.
  • Grill L, Dyer M, Lafferentz L, et al. Nano-architectures by covalent assembly of molecular building blocks. Nat Nanotechnol. 2007;2(11):687.
  • Sanchez C, Belleville P, Popall M, et al. Applications of advanced hybrid organic–inorganic nanomaterials: from laboratory to market. Chem Soc Rev. 2011;40(2):696–753.
  • Dong H, Hu W. Organic nanomaterials. In: Robert Vajtai, editor. Springer handbook of nanomaterials. Berlin, Heidelberg: Springer; 2013. p. 905–940.
  • Stark WJ, Stoessel PR, Wohlleben W, et al. Industrial applications of nanoparticles. Chem Soc Rev. 2015;44(16):5793–5805.
  • Chattopadhyay DK, Raju KVSN. Structural engineering of polyurethane coatings for high performance applications. Prog Polym Sci. 2007;32(3):352–418.
  • Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharm Res. 2006;23(1):1–30.
  • Lohse SE, Murphy CJ. Applications of colloidal inorganic nanoparticles: from medicine to energy. J Am Chem Soc. 2012;134(38):15607–15620.
  • Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev. 2006;35(7):583–592.
  • Advincula RC. Hybrid organic–inorganic nanomaterials based on polythiophene dendronized nanoparticles. Dalton Trans. 2006;23:2778–2784.
  • Walling M, Novak J, Shepard JR. Quantum dots for live cell and in vivo imaging. Int J Mol Sci. 2009;10(2):441–491.
  • Wang YA, Li JJ, Chen H, et al. Stabilization of inorganic nanocrystals by organic dendrons. J Am Chem Soc. 2002;124(10):2293–2298.
  • Locklin J, Patton D, Deng S, et al. Conjugated oligothiophene-dendron-capped CdSe nanoparticles: synthesis and energy transfer. Chem Mater. 2004;16(24):5187–5193.
  • Ma CQ, Mena‐Osteritz E, Debaerdemaeker T, et al. Functionalized 3D oligothiophene dendrons and dendrimers—novel macromolecules for organic electronics. Angew Chem. 2007;46(10):1679–1683.
  • Yao J, Yang M, Duan Y. Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy. Chem Rev. 2014;114(12):6130–6178.
  • Pantic I. Magnetic nanoparticles in cancer diagnosis and treatment: novel approaches. Rev Adv Mater Sci. 2010;26:67–73.
  • Valko MMHCM, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161–1208.
  • Kolosnjaj-Tabi J, Javed Y, Lartigue L, et al. The one year fate of iron oxide coated gold nanoparticles in mice. ACS Nano. 2015;9(8):7925–7939.
  • Berry CC. Possible exploitation of magnetic nanoparticle–cell interaction for biomedical applications. J Mater Chem. 2005;15(5):543–547.
  • Fang C, Zhang M. Multifunctional magnetic nanoparticles for medical imaging applications. J Mater Chem. 2009;19(35):6258–6266.
  • Kim BH, Lee N, Kim H, et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T 1 magnetic resonance imaging contrast agents. J Am Chem Soc. 2011;133(32):12624–12631.
  • Pallas-Areny R, Webster JG. Sensors and signal conditioning. New York (NY): John Wiley & Sons; 2012.
  • Mahmoudi M, Sant S, Wang B, et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1–2):24–46.
  • Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60(11):1252–1265.
  • Cheng W, Haedicke IE, Nofiele J, et al. Complementary strategies for developing Gd-free high-field T 1 MRI contrast agents based on MnIII porphyrins. J Med Chem. 2014;57(2):516–520.
  • Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228(3):760–767.
  • Gallo J, Long NJ, Aboagye EO. Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. Chem Soc Rev. 2013;42(19):7816–7833.
  • Weisser NE, Hall JC. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics. Biotechnol Adv. 2009;27(4):502–520.
  • Lee JH, Huh YM, Jun YW, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007;13(1):95.
  • Lee N, Yoo D, Ling D, et al. Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy. Chem Rev. 2015;115(19):10637–10689.
  • Skitzki JJ, Repasky EA, Evans SS. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Invest Drugs. 2009;10(6):550. London, England: 2000.
  • Kalambur VS, Longmire EK, Bischof JC. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir. 2007;23(24):12329–12336.
  • Tay ZW, Chandrasekharan P, Chiu-Lam A, et al. Magnetic particle imaging-guided heating in vivo using gradient fields for arbitrary localization of magnetic hyperthermia therapy. ACS Nano. 2018;12(4):3699–3713.
  • Berry CC. Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys. 2009;42(22):224003.
  • Medeiros SF, Santos AM, Fessi H, et al. Stimuli-responsive magnetic particles for biomedical applications. Int J Pharm. 2011;403(1–2):139–161.
  • Huang J, Li Y, Orza A, et al. Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image‐guided approaches. Adv Funct Mater. 2016;26(22):3818–3836.
  • Natarajan A, Sundrarajan R, DeNardo SJ. Magnetic nanoparticles for Cancer imaging and therapy. In Kumar CSSR, editor. Nanotechnologies for the Life Sciences; 2011.
  • Vekris A, Maurange C, Moonen C, et al. Control of transgene expression using local hyperthermia in combination with a heat‐sensitive promoter. J Gene Med. 2000;2(2):89–96.
  • Angelakeris M. Magnetic nanoparticles: A multifunctional vehicle for modern theranostics. Biochim Biophys Acta. 2017;1861(6):1642–1651.
  • Lunnoo T, Puangmali T. Capture efficiency of biocompatible magnetic nanoparticles in arterial flow: A computer simulation for magnetic drug targeting. Nanoscale Res Lett. 2015;10(1):426.
  • Lübbe AS, Bergemann C, Brock J, et al. Physiological aspects in magnetic drug-targeting. J Magn Magn Mater. 1999;194(1–3):149–155.
  • Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8(2):147-166.
  • Mykhaylyk O, Antequera YS, Vlaskou D, et al. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc. 2007;2(10):2391.
  • Dietz HC (1998). U.S. Patent No. 5,814,500. Washington, DC: U.S. Patent and Trademark Office.
  • Arsianti M, Lim M, Marquis CP, et al. Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery. Langmuir. 2010;26(10):7314–7326.
  • Davidson BL, McCray PB Jr. Current prospects for RNA interference-based therapies. Nat Rev Genet. 2011;12(5):329.
  • Zuckerman JE, Choi CHJ, Han H, et al. Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane. Proc Nat Acad Sci. 2012;109(8):3137–3142.
  • Min KA, Shin MC, Yu F, et al. Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers. ACS Nano. 2013;7(3):2161–2171.
  • Draz MS, Fang BA, Zhang P, et al. Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections. Theranostics. 2014;4(9):872.
  • Capek I. Polymer decorated gold nanoparticles in nanomedicine conjugates. Adv Colloid Interface Sci. 2017;249:386–399.
  • Jiang K, Smith DA, Pinchuk A. Size-dependent photothermal conversion efficiencies of plasmonically heated gold nanoparticles. J Phys Chem C. 2013;117(51):27073–27080.
  • Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev. 2009;38(6):1759–1782.
  • Padmanabhan P, Kumar A, Kumar S, et al. Nanoparticles in practice for molecular-imaging applications: an overview. Acta Biomater. 2016;41:1–16.
  • Chan J, Aoki C, Pickel VM. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods. 1990;33(2–3):113–127.
  • Pol ANVD. Neuronal imaging with colloidal gold. J Microsc. 1989;155(1):27–59.
  • Cho EC, Xie J, Wurm PA, et al. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett. 2009;9(3):1080–1084.
  • Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;9(Suppl 1):51.
  • Brewer SH, Glomm WR, Johnson MC, et al. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir. 2005;21(20):9303–9307.
  • Oh E, Delehanty JB, Sapsford KE, et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano. 2011;5(8):6434–6448.
  • Saha K, Agasti SS, Kim C, et al. Gold nanoparticles in chemical and biological sensing. Chem Rev. 2012;112(5):2739–2779.
  • Lu M, Hong L, Liang Y, et al. Enhancement of gold nanoparticle coupling with a 2D plasmonic crystal at high incidence angles. Anal Chem. 2018;90(11):6683–6692.
  • Zhao W, Brook MA, Li Y. Design of gold nanoparticle‐based colorimetric biosensing assays. ChemBioChem. 2008;9(15):2363–2371.
  • De Silva AP, Gunaratne HN, Gunnlaugsson T, et al. Signaling recognition events with fluorescent sensors and switches. Chem Rev. 1997;97(5):1515–1566.
  • Berry CC. Applications of inorganic nanoparticles for biotechnology. In Jesus M. de la Fuente, V. Grazu, editor. Frontiers of nanoscience. Vol. 4. Elsevier; 2012. p. 159–180.
  • Ruddy DA, Johnson JC, Smith ER, et al. Size and bandgap control in the solution-phase synthesis of near-infrared-emitting germanium nanocrystals. ACS Nano. 2010;4(12):7459–7466.
  • Yildiz I, Deniz E, McCaughan B, et al. Hydrophilic CdSe− ZnS core− shell quantum dots with reactive functional groups on their surface. Langmuir. 2010;26(13):11503–11511.
  • Breger J, Delehanty JB, Medintz IL. Continuing progress toward controlled intracellular delivery of semiconductor quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(2):131–151.
  • Sun C (2016). Microfluidic technology for cellular analysis and molecular biotechnology (Doctoral dissertation, Virginia Tech).
  • Wilson R. The use of gold nanoparticles in diagnostics and detection. Chem Soc Rev. 2008;37(9):2028–2045.
  • Renner M, Lacor PN, Velasco PT, et al. Deleterious effects of amyloid β oligomers acting as an extracellular scaffold for mGluR5. Neuron. 2010;66(5):739–754.
  • Rurack K, Spieles M. Fluorescence quantum yields of a series of red and near-infrared dyes emitting at 600− 1000 nm. Anal Chem. 2011;83(4):1232–1242.
  • Axelrod D. Total internal reflection fluorescence microscopy in cell biology. Traffic. 2001;2(11):764–774.
  • Tan M, Wang Y, Song X, et al. Nanomaterials as therapeutic/imaging agent delivery vehicles for tumor targeting theranostics. Nanomater Tumor Targeting Theranostics. 2016;1–42.
  • Hilderbrand SA, Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol. 2010;14(1):71–79.
  • Gao X, Yang L, Petros JA, et al. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol. 2005;16(1):63–72.
  • de Fougerolles A, Vornlocher HP, Maraganore J, et al. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007;6(6):443.
  • Gautam A, Kapoor P, Chaudhary K, et al., Source Drug Discovery Consortium. Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics. Curr Med Chem. 2014;21(21):2367–2391.
  • Tasis D, Tagmatarchis N, Bianco A, et al. Chemistry of carbon nanotubes. Chem Rev. 2006;106(3):1105–1136.
  • Li H, He X, Liu Y, et al. One-step ultrasonic synthesis of water-soluble carbon nanoparticles with excellent photoluminescent properties. Carbon. 2011;49(2):605–609.
  • Fabbro A,Cellot G, Prato M, et al. Interfacing neurons with carbon nanotubes: (re) engineering neuronal signaling. Progress in Brain Research. 2011;194:241–252.
  • Martinelli V, Cellot G, Toma FM, et al. Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myocytes. Nano Lett. 2012;12(4):1831–1838.
  • Abdul Razak M, Boggupalli DP, Viswanath B. Drug-loaded nanocarriers in tumor targeted drug delivery. Curr Biotechnol. 2015;4(3):319–344.
  • Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13(11):813.
  • Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol. 2010;28(11):570–579.
  • De Laporte L, Rea JC, Shea LD. Design of modular non-viral gene therapy vectors. Biomaterials. 2006;27(7):947–954.
  • Kim MH, Na HK, Kim YK, et al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano. 2011;5(5):3568–3576.
  • Kobiler O, Drayman N, Butin-Israeli V, et al. Virus strategies for passing the nuclear envelope barrier. Nucleus. 2012;3(6):526–539.
  • Zakharova L, Pashirova T, Kashapov R, et al. Drug delivery mediated by confined nanosystems: structure-activity relations and factors responsible for the efficacy of formulations. In: Andronescu E, Grumezescu AM, editor. Nanostructures for drug delivery. Bucharest (Romania): Elsevier; 2017. p. 749–806.
  • El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release. 2004;94(1):1–14.
  • Shi X, Sanedrin RJ, Zhou F. Structural characterization of multilayered DNA and polylysine composite films: influence of ionic strength of DNA solutions on the extent of DNA incorporation. J Phys Chem A. 2002;106(6):1173–1180.
  • Uz M, Altinkaya SA, Mallapragada SK. Stimuli responsive polymer-based strategies for polynucleotide delivery. J Mater Res. 2017;32(15):2930–2953.
  • Li Z, Barnes JC, Bosoy A, et al. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev. 2012;41(7):2590–2605.
  • Xu J, Ganesh S, Amiji M. Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery. Int J Pharm. 2012;427(1):21–34.
  • Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev. 2006;58(4):467–486.
  • Khatak S, Dureja H. Recent techniques and patents on solid lipid nanoparticles as novel carrier for drug delivery. Recent Pat Nanotechnol. 2015;9(3):150–177.
  • Krishnamoorthy M (2016). Developing cationic nanoparticles for gene delivery (Doctoral dissertation, Queen Mary University of London).
  • Vonarbourg A, Passirani C, Desigaux L, et al. The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials. 2009;30(18):3197–3204.
  • Zahr AS, Davis CA, Pishko MV. Macrophage uptake of core− shell nanoparticles surface modified with poly (ethylene glycol). Langmuir. 2006;22(19):8178–8185.
  • Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles. Sci Technol Adv Mater. 2010;11(1):014104.
  • Nanjwade BK, Bechra HM, Derkar GK, et al. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci. 2009;38(3):185–196.
  • Dufes C, Uchegbu IF, Schätzlein AG. Dendrimers in gene delivery. Adv Drug Deliv Rev. 2005;57(15):2177–2202.
  • Esfand R, Tomalia DA. Poly (amidoamine)(PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6(8):427–436.
  • Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev. 2012;64:102–115.
  • Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157(2):168–182.
  • Zhang J, Chua LS, Lynn DM. Multilayered thin films that sustain the release of functional DNA under physiological conditions. Langmuir. 2004;20(19):8015–8021.
  • Verma C, Janghel A, Deo S, et al. A comprehensive advancement on nanomedicines along with its various biomedical applications. Res J Pharm Technol. 2015;8(7):945–957.
  • Feracci H, Gutierrez BS, Hempel W, et al. Organic nanoparticles. In: Jesus M. de la Fuente, Grazu V, editor. Frontiers of nanoscience. Vol. 4. Spain: Elsevier; 2012. p. 197–230.
  • Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull. 2010;58(11):1423–1430.
  • Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70(3):399–421.
  • Elzoghby AO. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J Control Release. 2013;172(3):1075–1091.
  • Kaul G, Amiji M. Biodistribution and targeting potential of poly (ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J Drug Target. 2004;12(9–10):585–591.
  • Kaul G, Amiji M (2004). Biodistribution and tumor-targeting potential of poly (Ethylene Glycol)-modified gelatin nanoparticles. MRS Online Proceedings Library Archive, 845.
  • Xu L, Pirollo KF, Chang EH. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release. 2001;74(1–3):115–128.
  • Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev. 2003;55(2):199–215.
  • Oba M, Aoyagi K, Miyata K, et al. Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Mol Pharm. 2008;5(6):1080–1092.
  • Chen MC, Mi FL, Liao ZX, et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev. 2013;65(6):865–879.
  • Kou L, Sun J, Zhai Y, et al. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci. 2013;8(1):1–10.
  • Thomas M, Klibanov AM. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol. 2003;62(1):27–34.
  • Swami R, Singh I, Khan W, et al. Diseases originate and terminate by genes: unraveling nonviral gene delivery. Drug Deliv Transl Res. 2013;3(6):593–610.
  • De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59(4–5):292–307.
  • Gaj T, Gersbach CA, Barbas CF III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013;31(7):397–405.
  • Liu R, Wu P, Yang L, et al. Inductively coupled plasma mass spectrometry‐based immunoassay: A review. Mass Spectrom Rev. 2014;33(5):373–393.
  • Sackmann EK, Fulton AL, Beebe DJ. The present and future role of microfluidics in biomedical research. Nature. 2014;507(7491):181.
  • Sittampalam G (1982). PREPARATION AND PROPERTIES OF ANTIGEN-OR ANTIBODY-ENZYME CONJUGATES EMPLOYED IN ENZYME IMMUNOASSAYS.
  • Paschinger K, Rendić D, Wilson IB. Revealing the anti-HRP epitope in Drosophila and Caenorhabditis. Glycoconj J. 2009;26(3):385–395.
  • Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260(6):3440–3450.
  • Koutsoumpeli E, Tiede C, Murray J, et al. Antibody mimetics for the detection of small organic compounds using a quartz crystal microbalance. Anal Chem. 2017;89(5):3051–3058.
  • Nel AE, Mädler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater. 2009;8(7):543.
  • Sharma D, Kanchi S, Bisetty K. Biogenic synthesis of nanoparticles: a review. Arab J Chem. 2019;12(8):3576-3600.
  • Rodriguez-Docampo Z, Pascu SI, Kubik S, et al. Noncovalent interactions within a synthetic receptor can reinforce guest binding. J Am Chem Soc. 2006;128(34):11206–11210.
  • Niemeyer CM, Sano T, Smith CL, et al. Oligonucleotide-directed self-assembly of proteins: semisynthetic DNA—streptavidin hybrid molecules as connectors for the generation of macroscopic arrays and the construction of supramolecular bioconjugates. Nucleic Acids Res. 1994;22(25):5530–5539.
  • Wakefield DH, Rozema DB, Wolff JA, et al. (2006). U.S. Patent No. 7,094,605. Washington, DC: U.S. Patent and Trademark Office.
  • Shipunova VO, Zelepukin IV, Stremovskiy OA, et al. Versatile platform for nanoparticle surface bioengineering based on SiO2-binding peptide and proteinaceous barnase* barstar interface. ACS Appl Mater Interfaces. 2018;10(20):17437–17447.
  • Zhang Y, Heller A. Reduction of the nonspecific binding of a target antibody and of its enzyme-labeled detection probe enabling electrochemical immunoassay of an antibody through the 7 pg/mL− 100 ng/mL (40 fM− 400 pM) range. Anal Chem. 2005;77(23):7758–7762.
  • Cho EJ, Lee JW, Ellington AD. Applications of aptamers as sensors. Ann Rev Anal Chem. 2009;2:241–264.
  • Dhawan S. Design and construction of novel molecular conjugates for signal amplification (II): use of multivalent polystyrene microparticles and lysine peptide chains to generate immunoglobulin–horseradish peroxidase conjugates. Peptides. 2002;23(12):2099–2110.
  • Kim S, Pyo HB, Ko SH, et al. Fabrication of anionic sulfate-functionalized nanoparticles as an immunosensor by protein immobilization. Langmuir. 2010;26(10):7355–7364.
  • Fernando LP, Kandel PK, Yu J, et al. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules. 2010;11(10):2675–2682.
  • Trau D, Yang W, Seydack M, et al. Nanoencapsulated microcrystalline particles for superamplified biochemical assays. Anal Chem. 2002;74(21):5480–5486.
  • Chan CPY, Bruemmel Y, Seydack M, et al. Nanocrystal biolabels with releasable fluorophores for immunoassays. Anal Chem. 2004;76(13):3638–3645.
  • Origoni M, Cristoforoni P, Carminati G, et al. E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective. Ecancermedicalscience. 2015;9:533.
  • Ho JAA, Wu LC, Huang MR, et al. Application of ganglioside-sensitized liposomes in a flow injection immunoanalytical system for the determination of cholera toxin. Anal Chem. 2007;79(1):246–250.
  • Théry M, Racine V, Piel M, et al. Anisotropy of cell adhesive microenvironment governs cell internal organization and orientation of polarity. Proc Nat Acad Sci. 2006;103(52):19771–19776.
  • Hu G, Place AT, Minshall RD. Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol Interact. 2008;171(2):177–189.
  • Lambert M, Padilla F, Mège RM. Immobilized dimers of N-cadherin-Fc chimera mimic cadherin-mediated cell contact formation: contribution of both outside-in and inside-out signals. J Cell Sci. 2000;113(12):2207–2219.
  • Morini MF (2014). VE-cadherin orchestrates epigenetic modifications aimed at endothelial stabilisation.
  • Van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23):3756–3788.
  • Sanchez‐Martin RM, Muzerelle M, Chitkul N, et al. Bead‐based cellular analysis, sorting and multiplexing. ChemBioChem. 2005;6(8):1341–1345.
  • Zimmerman LB, De Jesús-Escobar JM, Harland RM. The spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 1996;86(4):599–606.
  • Van Nhieu GT, Ben‐Ze’ev A, Sansonetti PJ. Modulation of bacterial entry into epithelial cells by association between vinculin and the shigella IpaA invasin. Embo J. 1997;16(10):2717–2729.
  • Kienberger F, Ebner A, Gruber HJ, et al. Molecular recognition imaging and force spectroscopy of single biomolecules. Acc Chem Res. 2006;39(1):29–36.
  • Cassano AG, Anderson VE, Harris ME. Understanding the transition states of phosphodiester bond cleavage: insights from heavy atom isotope effects. Biopolymers. 2004;73(1):110–129.
  • Schumakovitch I, Grange W, Strunz T, et al. Temperature dependence of unbinding forces between complementary DNA strands. Biophys J. 2002;82(1):517–521.
  • Camesano TA, Liu Y, Datta M. Measuring bacterial adhesion at environmental interfaces with single-cell and single-molecule techniques. Adv Water Res. 2007;30(6–7):1470–1491.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.